Concourse Financial Group Securities, Inc. Gh Research PLC Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GHRS
# of Institutions
34Shares Held
28.3MCall Options Held
10.3KPut Options Held
3.7K-
Bvf Inc San Francisco, CA10.4MShares$125 Million2.72% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$80.6 Million0.76% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.86MShares$58.6 Million13.21% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$40.1 Million0.38% of portfolio
-
Verition Fund Management LLC Greenwich, CT918KShares$11.1 Million0.03% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $627M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...